A new paradigm to monitor and stimulate the brain

tDCS / EEG

Mobile brain signal sensing and stimulation systems

Enobio
Starstim

Use cases

Neuropathic pain

Helping SCI patients reduce their pain

See more

Cognitive enhancement

Improving mathematical abilities in children with dyscalculia

See more

Brain Computer Interfaces

Making possible for the first time brain to brain communication

See more

Team

NE® team

Ana Maiques

CEO

Ana Maiques is the CEO of Neuroelectrics, a company aiming to change the way we interact with the brain, developing innovative technologies to monitor and stimulate the brain to help many patients in need. She was nominated by IESE...

See more
NE® team

Giulio Ruffini

President

Dr. Giulio Ruffini obtained a BA in math and physics from Berkeley and a PhD in theoretical physics from UC Davis/LANL in 1995. In 2000 he and others founded Starlab to transform science into technologies with impact. He has provided the science and technology visions for Neuroelectrics, and believes that neuromodulation will make great advances thanks to the union of precision multifocal stimulation technologies with advanced biophysical and neuro-computational models, EEG and fMRI. His recent paper on brain-to-brain communication was the 9th most shared paper of 2014.

See more
NE® team

Uri Fligil

Marketing

Uri coursed Business Management in Israel (The College of Management) and an MBA at IESE Business School. He has worked intensively in Israel, Switzerland, USA, Holland and Spain, having acquired great experience in the medical sector. Just after graduating, he launched a start-up in the cardiovascular field in his homeland: Israel. Before joining Neuroelectrics, Uri worked at Medtronic,...

See more
NE® team

Paul Pyzowski

Corporate Development

Paul graduated with a BS in Electrical Engineering from Carnegie-Mellon University in Pittsburgh PA, and an MBA from the Institute for Management Development (IMD) in Lausanne, Switzerland. Paul has been a founder and executive in several life sciences start-up companies, including Aleva Neurotherapeutics, a spin-off from the Swiss Federal Institute of Technology of Lausanne (EPFL) developing advanced deep-brain stimulation systems for treatment of Parkinson’s disease and other movement disorders, and NetBio (Waltham, MA), a spin-off from the Whitehead Institute at MIT developing rapid DNA analysis systems for defense, security, and infectious disease diagnostics. Prior to this, Paul was an executive officer with the electronics technology company Ansoft Corporation (NASDAQ:ANST, acquired by ANSYS) where, among...

See more
Advisory Board

Alvaro Pascual-Leone, MD, PhD

BIDMC/Harvard Medical School


Prof. Adam Gazzaley

Neuroscience Imaging Center / UC San Francisco


Prof. Roi Cohen Kadosh

Kadosh Lab, U. of Oxford


Prof. Michael Nitsche

Leibniz Research Centre for Working Environment and Human Factors


Prof. Niels Birbaumer

University of Tübingen

Cookie policy:

By using our website you are consenting to our use of cookies in accordance with our Cookie Policy. OK